I agree that this site is using cookies. You can find further informations here.
X
Park, Haeseong
182  results:
Search for persons X
?
1

Phase 1b study to assess the safety, tolerability, and clin..:

Stradella, Agostina ; Johnson, Melissa ; Goel, Sanjay...
Cancer Medicine.  13 (2024)  13 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

PD-L1 has a heterogeneous and dynamic expression in gastric..:

Ibrahim, Dina ; Simó, Cristina ; Brown, Emma L....
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

Context-dependent activation of STING-interferon signaling ..:

Liu, Xiuting ; Hogg, Graham D. ; Zuo, Chong...
Cancer Cell.  41 (2023)  6 - p. 1073-1090.e12 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Antitumour activity of neratinib in patients with HER2-muta..:

Harding, James J. ; Piha-Paul, Sarina A. ; Shah, Ronak H....
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
5

Transferrin receptor in primary and metastatic breast cance..:

Fontana, Francesca ; Esser, Alison K. ; Egbulefu, Christopher...
PLOS ONE.  18 (2023)  12 - p. e0293700 , 2023
Link: https://doi.org/10.1371/..
 
?
6

Medium optimization for growth of Bacillus amyloliquefacien..:

Choi, Kang-Hyun ; Seo, Sun Il ; Park, Haeseong..
Journal of Plant Biotechnology.  49 (2022)  4 - p. 356-361 , 2022
Link: https://doi.org/10.5010/..
 
?
7

Screening of Carbofuran-Degrading Bacteria Chryseobacterium..:

Park, Haeseong ; Seo, Sun Il ; Lim, Ji-Hwan...
Metabolites.  12 (2022)  3 - p. 219 , 2022
Link: https://doi.org/10.3390/..
 
?
8

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist ..:

Yap, Timothy A. ; Gainor, Justin F. ; Callahan, Margaret K....
Clinical Cancer Research.  28 (2022)  17 - p. 3695-3708 , 2022
Link: https://doi.org/10.1158/..
 
?
9

Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Pacl..:

Grierson, Patrick M ; Tan, Benjamin ; Pedersen, Katrina S...
The Oncologist.  28 (2022)  2 - p. e115-e123 , 2022
Link: https://doi.org/10.1093/..
 
?
10

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with i..:

Bagegni, Nusayba A. ; Park, Haeseong ; Kraft, Katlyn...
Cancer Chemotherapy and Pharmacology.  89 (2022)  4 - p. 487-497 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Manufacturing‐dependent change in biological activity of th..:

Steeghs, Neeltje ; Hansen, Aaron R. ; Hanna, Glenn J....
Clinical and Translational Science.  15 (2022)  11 - p. 2625-2639 , 2022
Link: https://doi.org/10.1111/..
 
?
12

A dose-escalation and expansion study of the safety and pha..:

Tolcher, Anthony ; Vandross, Andrae ; Johnson, Melissa...
Gynecologic Oncology.  166 (2022)  - p. S158 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Re-examining The Time-varying Relationship Between Health a..:

Jeong, Minsoo ; Kim, Chang Sik ; Park, Haeseong
International Economic Journal.  36 (2022)  2 - p. 158-170 , 2022
Link: https://doi.org/10.1080/..
 
?
14

A single-institution phase I feasibility study of dose-esca..:

Vlacich, Gregory ; Ballard, Andrew ; Badiyan, Shahed N....
Clinical and Translational Radiation Oncology.  30 (2021)  - p. 19-25 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Production of (−)-α-bisabolol in metabolically engineered S..:

Kim, Tae Yeob ; Park, Haeseong ; Kim, Sun-Ki..
Journal of Biotechnology.  340 (2021)  - p. 13-21 , 2021
Link: https://doi.org/10.1016/..
 
1-15